Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MPPED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TGFB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BST2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APRT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIDT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC283352 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DKK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BMP8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APBB1IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC44A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCN3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGHM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLCO5A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on